Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer

Go back to Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
(NASDAQ: ACRV) Delayed: 1.76 --0 (-0%)
Previous Close $1.76    52 Week High $ 
Open $1.76    52 Week Low $ 
Day High $1.76    P/E N/A 
Day Low $1.76    EPS $ 
Volume 655